Freedom Investment Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-805
Closed -$218K 794
2024
Q1
$218K Sell
805
-343
-30% -$81.9K 0.02% 715
2023
Q4
$271K Sell
1,148
-269
-19% -$52.9K 0.02% 626
2023
Q3
$278K Buy
1,417
+4
+0.3% +$821 0.03% 535
2023
Q2
$297K Sell
1,413
-358
-20% -$71.2K 0.03% 546
2023
Q1
$357K Buy
1,771
+574
+48% +$130K 0.04% 501
2022
Q4
$261K Sell
1,197
-25
-2% -$5.46K 0.03% 608
2022
Q3
$240K Sell
1,222
-39
-3% -$8.42K 0.03% 615
2022
Q2
$270K Buy
1,261
+7
+0.6% +$1.71K 0.03% 607
2022
Q1
$356K Sell
1,254
-678
-35% -$209K 0.03% 574
2021
Q4
$728K Buy
1,932
+58
+3% +$22.5K 0.05% 435
2021
Q3
$773K Sell
1,874
-195
-9% -$81K 0.06% 392
2021
Q2
$765K Sell
2,069
-109
-5% -$36.4K 0.06% 408
2021
Q1
$631K Sell
2,178
-595
-21% -$165K 0.05% 447
2020
Q4
$693K Sell
2,773
-300
-10% -$71.4K 0.08% 256
2020
Q3
$696K Sell
3,073
-600
-16% -$125K 0.08% 222
2020
Q2
$640K Sell
3,673
-1,166
-24% -$186K 0.07% 217
2020
Q1
$755K Buy
4,839
+1,630
+51% +$244K 0.07% 242
2019
Q4
$490K Sell
3,209
-2,130
-40% -$295K 0.04% 349
2019
Q3
$707K Buy
5,339
+1,448
+37% +$194K 0.06% 280
2019
Q2
$552K Sell
3,891
-2,467
-39% -$335K 0.05% 336
2019
Q1
$923K Sell
6,358
-799
-11% -$105K 0.07% 252
2018
Q4
$810K Buy
7,157
+1,608
+29% +$201K 0.06% 309
2018
Q3
$692K Buy
5,549
+169
+3% +$20.9K 0.04% 419
2018
Q2
$604K Buy
+5,380
New +$582K 0.04% 475
2017
Q4
Sell
-4,238
Closed -$458K 1139
2017
Q3
$458K Buy
4,238
+428
+11% +$44K 0.03% 636
2017
Q2
$385K Buy
3,810
+357
+10% +$32.9K 0.02% 676
2017
Q1
$311K Buy
+3,453
New +$293K 0.02% 747
2016
Q4
Sell
-3,485
Closed -$290K 992
2016
Q3
$290K Buy
3,485
+98
+3% +$8.21K 0.02% 654
2016
Q2
$279K Buy
3,387
+372
+12% +$30.6K 0.02% 616
2016
Q1
$229K Buy
+3,015
New +$223K 0.02% 681

Other funds holding CRL